Deal Watch: Shire Increases Rare Disease Holdings, Abbott Expands Latin American Interests
Executive Summary
MedImmune and Bristol announce immuno-oncology combination trials with new partners on the same day, while AC Immune and Piramal Imaging will collaborate to develop an Alzheimer’s diagnostic to trace abnormal Tau protein in neuronal tissue.